Journal of Applied Physiology Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


J Appl Physiol (November 8, 2007). doi:10.1152/japplphysiol.00329.2007
This Article
Right arrow Full Text (PDF) Free
Right arrow All Versions of this Article:
104/2/394    most recent
00329.2007v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sorkness, R. L.
Right arrow Articles by Wenzel, S. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sorkness, R. L.
Right arrow Articles by Wenzel, S. E.
Submitted on March 23, 2007
Accepted on November 7, 2007

Lung Function in Adults with Stable but Severe Asthma: Air Trapping and Incomplete Reversal of Obstruction with Bronchodilation

Ronald L. Sorkness1*, Eugene R. Bleecker2, William W. Busse3, William J. Calhoun4, Mario Castro5, Kian Fan Chung6, Douglas Curran-Everett7, Serpil C. Erzurum8, Benjamin M. Gaston9, Elliot Israel10, Nizar N. Jarjour11, Wendy C. Moore12, Stephen P. Peters12, W. Gerald Teague13, and Sally E. Wenzel14

1 Department of Pharmacy Medicine & Pediatrics, University of Wisconsin, Madison, Wisconsin, United States
2 Center for Human Genomics, Wake Forest University, Winston-Salem, United States; Section on Pulmonary, Critical Care, Allergy & Immunologic Diseases, United States
3 Allergy, U Wisconsin Medical School, Madison, Wisconsin, United States
4 Medicine-APICS, UTMB, 5.132 JSA Rt 0561, Galveston, Texas, 77555-0561, United States; Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, United States
5 Medicine, Washington University, St. Louis, Missouri, United States
6 Department of Thoracic Medicine, National Heart & Lung Institute, London, United Kingdom
7 Biostatistics, M222, National Jewish Med Research Center, Denver, Colorado, United States
8 Pathobiology, Cleveland Clinic, Cleveland, Ohio, United States
9 Pediatrics, UVA Sch Med, Charlottesville, Virginia, United States
10 Medicine, Brigham & Women's Hospital, Boston, Massachusetts, United States
11 Medicine, University of Wisconsin, Madison, Wisconsin, United States
12 Center for Human Genomics, Wake Forest University, Winston-Salem, United States
13 Pediatrics, Emory University, Atlanta, Georgia, United States
14 National Jewish Medical & Research Center, Denver, Colorado, United States

* To whom correspondence should be addressed. E-mail: rlsorkne{at}wisc.edu.

5-10% of asthma cases are poorly controlled chronically and refractory to treatment, and these severe cases account for disproportionate asthma-associated morbidity, mortality, and health care utilization. While persons with severe asthma tend to have more airway obstruction, it is not known whether they represent the severe tail of a unimodal asthma population, or a severe asthma phenotype. We hypothesized that severe asthma has a characteristic physiology of airway obstruction, and we evaluated spirometry, lung volumes, and reversibility during a stable interval in 287 severe and 382 non-severe asthma subjects from the Severe Asthma Research Program. We partitioned airway obstruction into components of air trapping (indicated by FVC) and airflow limitation (indicated by FEV1/FVC). Severe asthma had prominent air trapping, evident as reduced FVC over the entire range of FEV1/FVC. This pattern was confirmed with measures of RV/TLC in a subgroup. In contrast, non-severe asthma did not exhibit prominent air trapping, even at FEV1/FVC<75% predicted. Air trapping also was associated with increases in total lung capacity and functional reserve capacity. After maximal bronchodilation, FEV1 reversed similarly from baseline in severe and non-severe asthma, but the severe asthma classification was an independent predictor of residual reduction in FEV1 after maximal bronchodilation. An increase in FVC accounted for most of the reversal of FEV1 when baseline FEV1 was <60% predicted. We conclude that air trapping is a characteristic feature of the severe asthma population, suggesting that there is a pathological process associated with severe asthma that makes airways more vulnerable to this component.




This article has been cited by other articles:


Home page
ERRHome page
P-R. Burgel, J. de Blic, P. Chanez, C. Delacourt, P. Devillier, A. Didier, J-C. Dubus, I. Frachon, G. Garcia, M. Humbert, et al.
Update on the roles of distal airways in asthma
Eur. Respir. Rev., June 1, 2009; 18(112): 80 - 95.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
E. E. de Lange, T. A. Altes, J. T. Patrie, J. J. Battiston, A. P. Juersivich, J. P. Mugler III, and T. A. Platts-Mills
Changes in Regional Airflow Obstruction over Time in the Lungs of Patients with Asthma: Evaluation with 3He MR Imaging
Radiology, February 1, 2009; 250(2): 567 - 575.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
A. Busacker, J. D. Newell Jr, T. Keefe, E. A. Hoffman, J. C. Granroth, M. Castro, S. Fain, and S. Wenzel
A Multivariate Analysis of Risk Factors for the Air-Trapping Asthmatic Phenotype as Measured by Quantitative CT Analysis
Chest, January 1, 2009; 135(1): 48 - 56.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
D. G. Chapman, N. Berend, G. G. King, and C. M. Salome
Increased airway closure is a determinant of airway hyperresponsiveness
Eur. Respir. J., December 1, 2008; 32(6): 1563 - 1569.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
M. A. Seibold, B. Wang, C. Eng, G. Kumar, K. B. Beckman, S. Sen, S. Choudhry, K. Meade, M. Lenoir, H. G. Watson, et al.
An african-specific functional polymorphism in KCNMB1 shows sex-specific association with asthma severity
Hum. Mol. Genet., September 1, 2008; 17(17): 2681 - 2690.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
P. T. Macklem and C. G. Irvin
Dividing the FEV1 into its component parts
J Appl Physiol, July 1, 2008; 105(1): 392 - 392.
[Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
R. L. Sorkness
Reply to Macklem and Irvin
J Appl Physiol, July 1, 2008; 105(1): 393 - 393.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 1948 by the American Physiological Society.